Clinical Trial Update: When to Start Anti-HIV Drugs in Patients With Opportunistic Infections [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update reports findings on when to start antiretroviral therapy in patients with opportunistic HIV infections, aiming to optimize ti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aids-related Opportunistic Infections
• HIV Infection

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, AIDS-Related Opportunistic Infections | Phase 4 | Status: COMPLETED